ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024
[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
Abstract readMulticenter StudyEnglish Abstract
In one paragraph
Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors.
X S ZhangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
B C LiuNational Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
X DuThe Second People's Hospital of Shenzhen, Shenzhen 518035, China.
Y L ZhangHenan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
N XuNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
X L LiuNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
W M LiUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
H LinFirst Hospital of Jilin University, Changchun 130021, China.
R LiangXijing Hospital, Airforce Military Medical University, Xi'an 710032, China.
C Y ChenQilu Hospital of Shandong University, Jinan 250012, China.
J HuangThe Fourth Affiliated Hospital of Zhejiang University, Hangzhou 322000, China.
Y F YangInstitute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
H L ZhuInstitute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
L PanInstitute of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
X D WangSichuan Academy of Medical Sciences Sichuan Provincial People's Hospital, Chengdu 610072, China.
G H LiXi'an International Medical Center Hospital, Xi'an 710038, China.
Z G LiuShengjing Hospital of China Medical University, Shenyang 110020, China.
Y Q ZhangThe Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
Z F LiuThe First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
J D HuFujian Medical University Union Hospital, Fuzhou 350001, China.
C S LiuFirst Hospital of Jilin University, Changchun 130021, China.
F LiThe First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
W YangShengjing Hospital of China Medical University, Shenyang 110020, China.
L MengTongji Hospital of Tongji Medical College, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
Y Q HanThe Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China.
L E LinHainan General Hospital, Haikou 570311, China.
Z Y ZhaoHainan General Hospital, Haikou 570311, China.
C Q TuShenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen 518101, China.
C F ZhengShenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen 518101, China.
Y L BaiHenan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China.
Z P ZhouThe Second Hospital Affiliated to Kunming Medical University, Kunming 650106, China.
S N ChenNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou 215006, China.
H Y QiuNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou 215006, China.
L J YangXi'an International Medical Center Hospital, Xi'an 710117, China.
X L SunThe First Affiliated Hospital ofDalian Medical University, Dalian 116011, China.
H SunThe First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
L ZhouShanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Z L LiuHuazhong University of Science and Technology Union Shenzhen Hospital, Nanshan Hospital, Shenzhen 518000, China.
D Y WangHuazhong University of Science and Technology Union Shenzhen Hospital, Nanshan Hospital, Shenzhen 518000, China.
J X GuoThe Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
L P PangPeking University Shenzhen Hospital, Shenzhen 516473, China.
Q S ZengThe First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
X H SuoHandan Central Hospital, Handan 057150, China.
W H ZhangFirst Hospital of Shangxi Medical University, Taiyuan 300012, China.
Y J ZhengFirst Hospital of Shangxi Medical University, Taiyuan 300012, China.
Q JiangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Funding
National Natural Science Foundation of China 81970140
Abstract
PubMed holds no abstract for this paper.
Indexed as
DasatinibImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTyrosine Kinase InhibitorsAdultChinaFemaleHumansMaleMiddle AgedPyrimidinesRetrospective StudiesTreatment OutcomeDasatinibImatinib MesylatenilotinibPyrimidinesTyrosine Kinase InhibitorsLeukemia, myeloid, chronicMulti-centreReal-world studyTreatment statusTyrosine kinase inhibitor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.